Related Experiment Video
Updated: May 6, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.1K
Molecular genetics of human thyroid neoplasms
1Division of Endocrinology, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Annual Review of Medicine
|January 1, 1994
Summary
Cancer development involves sequential gene mutations. Genetic defects in oncogenes and tumor-suppressor genes offer insights into thyroid neoplasms, impacting future diagnosis and prognosis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancers are understood to arise from accumulated genetic mutations affecting cellular growth control.
- Specific genetic alterations in oncogenes and tumor-suppressor genes are crucial in neoplasm development.
Purpose of the Study:
- To review genetic defects implicated in benign and malignant thyroid neoplasms.
- To discuss the biological insights gained from studying these genetic alterations.
- To consider the future impact on thyroid tumor diagnosis and prognosis.
Main Methods:
- Review of recent scientific literature on genetic mutations in thyroid neoplasms.
- Analysis of identified genetic defects in oncogenes and tumor-suppressor genes.
- Synthesis of information regarding the biological mechanisms involved.
Main Results:
- Identification of key genetic defects contributing to thyroid tumor formation.
- Elucidation of the role of oncogenes and tumor-suppressor genes in thyroid neoplasia.
- Understanding the molecular basis of thyroid tumor biology.
Conclusions:
- Genetic mutations are fundamental to cancer development, including thyroid neoplasms.
- Studying genetic defects provides critical insights into thyroid tumor biology.
- These findings have significant implications for improving thyroid tumor diagnosis and prognosis.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
7.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K
Functions of Thyroid Hormones
5.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Hyperthyroidism I: Introduction
59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
Hyperthyroidism II: Pathophysiology
36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Graves' Disease I: Introduction
49
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49

